• Western blot analysis of lysates from SW480 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-MAGEB2 antibody (30-110 aa) (STJ191707)

SKU:
STJ191707

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Melanoma-associated antigen B2 (30-110 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MAGEB2
Gene ID: 4113
Uniprot ID: MAGB2_HUMAN
Immunogen Region: 30-110 aa
Specificity: MAGB2 Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 30-110
Function May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex.
Protein Name Melanoma-Associated Antigen B2
Cancer/Testis Antigen 3.2
Ct3.2
Dss-Ahc Critical Interval Mage Superfamily 6
Dam6
Mage Xp-2 Antigen
Mage-B2 Antigen
Alternative Antibody Names Anti-Melanoma-Associated Antigen B2 antibody
Anti-Cancer/Testis Antigen 3.2 antibody
Anti-Ct3.2 antibody
Anti-Dss-Ahc Critical Interval Mage Superfamily 6 antibody
Anti-Dam6 antibody
Anti-Mage Xp-2 Antigen antibody
Anti-Mage-B2 Antigen antibody
Anti-MAGEB2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance